Our findings align with this understanding, showing an escalation in TSLP and periostin levels concomitant with the reduction of the skin barrier proteins involucrin and loricrin in DNCB-induced AD-like skin conditions, which were subsequently ameliorated by I3C treatment (as shown in Fig. 4C). This evidence concerns the gene LORICRIN and Alzheimer disease.